Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
Advanced Drug Delivery Reviews · 2024-08 · 211 · 115359
DOI: 10.1016/j.addr.2024.115359 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024-08. Verfasst von Razan Masarwy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Precision Nanomedicine, The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv Univer…. Hauptthemen laut MEDLINE: Gene Editing, Nanoparticles, Lipids, CRISPR-Cas Systems. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 181 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Precision Nanomedicine, The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel; Department of Materials Sciences and Engineeri…
Zitieren
APA
Masarwy, R., Stotsky-Oterin, L., Elisha, A., Hazan-Halevy, I., & Peer, D. (2024). Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications. Advanced Drug Delivery Reviews, 211, 115359. https://doi.org/10.1016/j.addr.2024.115359
Vancouver
Masarwy R, Stotsky-Oterin L, Elisha A, Hazan-Halevy I, Peer D. Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications. Advanced Drug Delivery Reviews. 2024;211:115359. doi:10.1016/j.addr.2024.115359
BibTeX
@article{Masarwy2024,
author = {Masarwy, Razan and Stotsky-Oterin, Lior and Elisha, Aviad and Hazan-Halevy, Inbal and Peer, Dan},
title = {Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications},
journal = {Advanced Drug Delivery Reviews},
year = {2024},
volume = {211},
pages = {115359},
doi = {10.1016/j.addr.2024.115359}
}
EUVIMED